The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mccallum Stewart since 2016.
The trader's CIK number is 1659872.
At the time of the last reporting, Mccallum Stewart was the Chief Medical Officer of Recro Pharma, Inc.. (stock ticker symbol REPH).
Also see all insider trading activities at Recro Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | REPH | 0 | $0 | 0 | $0 | 6,000 | $0 |
| 2017 | REPH | 0 | $0 | 0 | $0 | 15,000 | $0 |
| 2016 | REPH | 1,250 | $10,275 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-18 | REPH | Option Ex | 6,000 | .00 | 0 |
| 2017-09-28 | REPH | Option Ex | 15,000 | .00 | 0 |
| 2016-05-31 | REPH | Buy | 250 | 8.50 | 2,125 |
| 2016-05-26 | REPH | Buy | 1,000 | 8.15 | 8,150 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mccallum Stewart (Chief Medical Officer of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.